Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study
Purpose: Little data are available regarding the safety and efficacy of s witching to Pasireotide-LAR monotherapy in acromegaly patients with partial resistance to first-generation somatostatin agonists (1gSRL) who require combination treatment with cabergoline or pegvisomant. Method: In this mono...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2019-10-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/8/10/EC-19-0332.xml |